Acceptability, Facilitators, and Barriers of Long-Acting Injectable Cabotegravir/Rilpivirine Among Youth With HIV in the United States
{{output}}
Purpose: Implementation data on long-acting injectable cabotegravir/rilpivirine (LAI-CAB/RPV) among adolescents and youth with HIV (AYWH) remain sparse. We aimed to evaluate the acceptability, facilitators, and barriers of LAI-CA... ...
